Sequence Similarity Clusters for the Entities in PDB 1G9N

Entity #1 | Chains: G
ENVELOPE GLYCOPROTEIN GP120 protein, length: 313 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 6 9 2854
95 % 6 9 3577
90 % 8 12 2729
70 % 83 126 179
50 % 83 126 218
40 % 83 126 240
30 % 83 129 245
Entity #2 | Chains: C
T-CELL SURFACE GLYCOPROTEIN CD4 protein, length: 185 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 21 37 719
95 % 25 42 851
90 % 25 42 886
70 % 25 42 919
50 % 25 42 971
40 % 25 42 991
30 % 25 42 967
Entity #3 | Chains: L
ANTIBODY 17B, LIGHT CHAIN protein, length: 214 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 39358
95 % 19 24 1484 Flexibility: Low
Max RMSD: 3.5, Avg RMSD: 0.7
PDBFlex
90 % 469 676 3
70 % 1277 1822 2
50 % 3114 4489 1
40 % 3114 4489 1
30 % 3647 5290 1
Entity #4 | Chains: H
ANTIBODY 17B, HEAVY CHAIN protein, length: 229 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 38162
95 % 19 24 1482 Flexibility: Low
Max RMSD: 2.3, Avg RMSD: 0.8
PDBFlex
90 % 19 24 1509
70 % 1505 2172 1
50 % 3115 4489 1
40 % 3115 4489 1
30 % 3648 5290 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
3 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
4 1MEX 1 L Fab 29G12 light chain 10090
5 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
6 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
7 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
8 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
9 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
10 4XCF 1 L 4E10 Fab light chain 9606
11 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
12 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
13 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
14 5X08 2 L Fab 4E10 Light chain 9606
15 4XAW 1 L 4E10 Fab light chain 9606
16 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
17 2VXV 2 L HUMAN IGG ABT-325 9606
18 2VXT 3 L MURINE IGG 125-2H 10090
19 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
20 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
21 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
22 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
23 4JG1 1 L Fab light chain 9606
24 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
25 5I8C 2 B VRC34.01 Fab light chain 9606
26 3IFL 1 L 12A11 FAB antibody light chain 10090
27 3PP4 2 L GA101 Fab light chain 10090
28 3KDM 1 A, L Immunoglobulin light chain 9606
29 5NIV 1 A Light chain of 5D3 Fab 10090
30 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
31 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
32 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
33 4PTU 1 A Antibody pn132p2C05, light chain 9606
34 4TPR 1 L If kappa light chain 10090
35 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
36 3IFN 2 L 12A11 FAB antibody light chain 10090
37 5U3P 2 L DH511.4 Fab Light Chain 9606
38 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
39 3NPS 3 C S4 FAB LIGHT CHAIN 9606
40 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
41 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
42 4XC3 1 L 4E10 Fab light chain 9606
43 4TQE 1 L If kappa light chain 10090
44 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
45 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
46 5JXA 2 L VRC03 Light chain 9606
47 3NTC 1 L Fab light chain 10090
48 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
49 4NWU 2 L APE1551 Ab Fab light chain 9606
50 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
51 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
52 5EWI 2 L VRC38.01 Light Chain 9606
53 5E2W 1 L AT8 LIGHT CHAIN 10090
54 4NZR 2 L PGT135 light chain Fab 9606
55 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
56 5UEL 2 L 354NC102 Fab Light Chain 9606
57 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
58 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
59 5E2V 1 L AT8 LIGHT CHAIN 10090
60 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
61 5JUE 1 L light chain of UIC2 Fab 10090
62 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
63 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
64 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
65 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
66 5I66 2 B 8B6 antibody, light chain 10090
67 3QQ9 1 C, L 101F LIGHT CHAIN 10090
68 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
69 5I1K 1 L FAB LIGHT CHAIN 9606
70 3OZ9 1 L Fab NC-1 kappa light chain 10090
71 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
72 5V7U 1 L CBTAU-22.1 Fab light chain 9606
73 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
74 3G5Y 1 A 175 light chain 10090
75 4N8C 2 L, M Light chain of monoclonal antibody 10090
76 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
77 4HGW 1 A Antibody Fab fragment, light chain 10090
78 1NLB 1 L antibody 19D9D6 light chain 10090
79 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
80 3VFG 1 L 3F8 Light Chain 10090
81 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
82 3QRG 1 L Fab light chain 9606
83 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
84 5EZI 2 L Fab c12 Light chain 9606
85 4K23 2 L anti-uPAR antibody, light chain 10090
86 3NCJ 1 L Fab15 Mut8 light chain 9606
87 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
88 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
89 5W05 1 L M59 FAB LIGHT CHAIN 10090
90 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
91 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
92 4M61 1 A, C Fab A52 light chain 10090
93 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
94 1UM5 1 L Antibody 21H3 L chain 10090
95 4NWT 1 L APE1531 Ab Fab light chain 9606
96 3WHX 2 B mAb Fab L fragment 10090
97 3NA9 1 L Fab15 light chain 9606
98 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
99 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
100 4LRI 1 A, B MSL-109 Light Chain 9606
101 4JN2 1 A, L anti dabigatran Fab 10090
102 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
103 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
104 4JFZ 1 L Fab light chain 9606
105 3WIF 2 B mAb Fab L fragment 10090
106 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
107 3MBX 1 L X836 LIGHT CHAIN 10090
108 4HHA 1 A Fab KE5 Fab fragment KE5 9606
109 4RGO 3 L 14G8 light chain Fab 10090
110 3NAA 1 L Fab15 Mut5 light chain 9606
111 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
112 5IK3 2 B, D 1E03 Fab fragment light chain 9606
113 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
114 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
115 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
116 5JOP 1 D, L Fab 14.22 light chain 10090
117 5IT2 2 L light chain 9606
118 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
119 4PUB 2 L DX-2930 LIGHT CHAIN 9606
120 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
121 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
122 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
123 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
124 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
125 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
126 3UYR 2 L antibody Fab light chain 10090
127 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
128 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
129 3OAZ 2 K, L Fab 2G12, light chain 9606
130 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
131 1ZAN 1 L Fab AD11 Light Chain 10116
132 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
133 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
134 5I8O 2 L HMM5 antibody light chain 9606
135 4JG0 1 L Fab light chain 9606
136 4YGV 2 B, L aDabi-Fab2a light chain 9606
137 3EO0 1 A, C GC-1008 Fab Light Chain 10090
138 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
139 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
140 4JHA 2 L D25 light chain 9606
141 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
142 4PTT 1 A Antibody pn132p2C05, light chain 9606
143 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
144 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
145 4DGV 2 L HCV1 Light Chain 9606
146 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
147 5TH2 1 A, C cetuximab Fab, light chain 10090
148 5I8K 1 L HHH1 Fab Light chain 9606
149 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
150 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
151 1YNL 1 L Ig gamma light chain 10090
152 5EPM 2 B, F Antibody Fab fragment light chain 10090
153 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
154 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
155 4NUJ 1 A PGT152 light chain 9606
156 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
157 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
158 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
159 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
160 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
161 4NUG 1 L PGT151 light chain 9606
162 3IU4 2 L chP3 Fab light chain 10090
163 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
164 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
165 1P7K 1 A, L antibody light chain FAB 10090
166 3RVV 2 C 4C1 - light chain 10090
167 3P0Y 3 L Fab DL11 light chain 9606
168 5IBU 1 B, L 6652 Light Chain 9606
169 5VPL 2 C 4C1 - LIGHT CHAIN 10090
170 2YPV 3 L FAB 12C1 10090
171 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
172 3NAC 1 L Fab15 Mut7 light chain 9606
173 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
174 1Q72 1 L Fab M82G2, Light chain 10090
175 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
176 4YHO 2 L aDabi-Fab3 light chain 9606
177 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
178 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
179 4DGY 2 L HCV1 Light Chain 9606
180 5EN2 2 B GD01 light chain 10090
181 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
182 3MXW 2 L 5E1 light chain 9606
183 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
184 3EO9 1 L Efalizumab Fab fragment, light chain 9606
185 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
186 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
187 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
188 5WUV 1 L light chain 9606
189 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
190 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
191 4JM4 2 L PGT 135 Light Chain Fab 9606
192 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
193 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
194 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
195 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
196 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
197 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
198 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
199 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
200 5TL5 1 L M2177 LIGHT CHAIN 10090
201 2FX7 1 L Fab 4E10 Light Chain 9606
202 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
203 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
204 3WFH 2 B mAb Fab L fragment 10090
205 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
206 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
207 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
208 3RVW 2 C 4C1 - light chain 10090
209 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
210 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
211 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
212 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
213 5I76 1 A, C FM318_light_chain 1383439
214 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
215 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
216 5I18 1 L FAB LIGHT CHAIN 9606
217 4JN1 2 L anti-dabigatran Fab1, light chain 10090
218 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
219 4G5Z 2 L canakinumab antibody fragment light chain 9606
220 2OK0 2 L Fab ED10 light chain 10090
221 3SOB 1 L antibody light chain 9606
222 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
223 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
224 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
225 5DR5 2 L AbD09097 Fab light chain 9606
226 2IH3 2 B FAB Light Chain 10090
227 4KQ3 1 L CNTO3186 light chain Fab 9606
228 4JFX 1 A, L Fab light chain 9606
229 3SGE 1 I, L Light Chain 10090
230 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
231 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
232 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
233 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
234 1JGU 1 L Antibody Light Chain 10090
235 4I77 2 L Lebrikizumab light chain Fab 9606
236 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
237 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
238 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
239 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
240 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
241 4HJG 1 A Trastuzumab light chain 9606
242 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
243 5I30 1 L Fab PL-2 light chain 10090
244 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
245 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
246 3FN0 1 L Fab Z13e1 light chain 9606
247 4YHI 2 B, L aDabi-Fab2a light chain 9606
248 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
249 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
250 1T2Q 1 L Fab NNA7 Heavy Chain 10090
251 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
252 4MAU 1 L C2244 light chain SEE REMARK 999 10090
253 3LEX 2 B, L 11f10 Antibody Light Chain 10090
254 1OP3 1 K, L FAB 2G12, light chain light chain 9606
255 5VH4 2 B, L Infliximab Fab Light Chain 10090
256 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
257 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
258 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
259 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
260 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
261 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
262 4LKX 2 B Fab fragment light chain 9606
263 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
264 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606
265 5JW5 2 B, L MEDI8852 Light chain 9606
266 5VH3 2 B, L Infliximab Fab Light Chain 10090
267 5HDQ 3 L Fab Light Chain 10090
268 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090
269 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090
270 2A77 1 L Immunoglobulin Light Chain 10090
271 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090
272 3QWO 1 B, L motavizumab light chain 10090
273 3CVI 2 L 25-D1.16 Light chain 10090
274 1PZ5 1 A Light chain of Fab (SYA/J6) 10090
275 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116
276 4IOI 1 A Trastuzumab light chain 9606
277 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090
278 4OKV 2 B, D light chain of 8H7 mAb 10090
279 1JGV 1 L Antibody Light Chain 10090
280 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090
281 5GIR 2 B, L Light chain of Fab fragment 10090
282 2ADF 3 L 82D6A3 IgG FAB 10090
283 5I16 1 A, L FAB LIGHT CHAIN 9606
284 3O41 1 B, L Mouse monoclonal antibody 101F Fab light chain 10090
285 5F9O 3 L CH235.09 Light chain 9606
286 1UM4 1 L Antibody 21H3 L chain 10090
287 4RBP 1 K, L Fab 2G12 light chain 9606
288 3I75 1 A Antibody heavy chain 10090
289 4XVS 2 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Light chain 9606
290 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606
291 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
292 1E6O 2 L IMMUNOGLOBULIN LIGHT CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') LIGHT CHAIN 1-210 10090
293 5GIS 2 L Light chain of Fab fragment 10090
294 1JFQ 1 L ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY LIGHT CHAIN 10090
295 5FGC 2 B Anti-HCV E2 Fab HC33.8 light chain 9606
296 4H20 1 L Light chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090
297 5GGQ 1 L nivolumab light chain 9606
298 3OAY 1 K, L Fab 2G12, light chain 9606
299 1CR9 1 L FAB ANTIBODY LIGHT CHAIN HEAVY CHAIN 10090
300 1A3L 1 L IMMUNOGLOBULIN FAB 13G5 (LIGHT CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090
301 1YEJ 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090
302 4GMT 1 L, M Fab S139/1 light chain 10090
303 5K9J 2 L 56.a.09 light chain 9606
304 3ZKM 3 D, L FAB LIGHT CHAIN 10090
305 1FNS 1 L IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, LIGHT CHAIN 10090
306 3HNS 2 L CS-35 Fab Light Chain Light Chain 10090
307 1KEL 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090
308 5TF1 2 L O2-CC Fab Light Chain 9606
309 3TCL 2 B, L CH04 Light Chain Fab 9606
310 4OJF 2 L Humanised 3D6 Fab Light Chain 10090
311 5F7E 2 L Fab light chain 9606
312 1N0X 1 L, M IMMUNOGLOBULIN LIGHT CHAIN UNP residues 132-239 9606
313 2FAT 1 L FAB ATN-615, light chain 10090
314 1RUL 1 L immunoglobulin igg2a, light chain fab 10090
315 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606
316 4WCY 2 L AZ130 Light chain 10090
317 5FHA 2 L Antibody 114 Fab light chain 9606
318 4H88 3 L POM1 FAB CHAIN L 10090
319 5UMN 3 D, F Antibody C05, light chain 9606
320 4X7S 2 L Ig kappa chain C region residues 23-236 9606
321 1UM6 1 L antibody 21h3, L chain 10090
322 5DD5 2 L ANTI-HIV ANTIBODY DH570.9 FAB HEAVY CHAIN 9544
323 2AK1 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
324 4X0K 2 B, L Fab fragment light chain 9606
325 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090
326 3HNV 2 L CS-35 Fab Light Chain Light Chain 10090
327 5E8E 1 A IGA FAB LIGHT CHAIN 9606
328 3LEY 2 L 6a7 Antibody Light Chain 10090
329 1YEI 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING DOMAIN 10090
330 3QPQ 1 C, E, I, L C1068 light chain 10090
331 2HFF 1 A, L CB2 Fab, light chain 9606
332 4M7K 1 L 10H10 light chain SEE REMARK 999 10090
333 1NDG 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-8 light chain 10090
334 3OKD 1 A S25-39 Fab (IgG1k) light chain 10090
335 2IPT 1 L IgG2a Fab fragment Heavy Chain 10090
336 1SBS 2 L MONOCLONAL ANTIBODY 3A2 FAB FRAGMENT 10090
337 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606
338 4YDK 3 L LIGHT CHAIN OF ANTIBODY C38-VRC16.01 9606
339 4MA3 1 A, L C2095 light chain SEE REMARK 999 9986
340 5GGS 2 B, D light chain 9606
341 2FBJ 1 L IGA-KAPPA J539 FAB (LIGHT CHAIN) 10090
342 1RUQ 1 L immunoglobulin 13G5 light chain fab 10090
343 2HKF 1 L Immunoglobulin Light chain Fab fragment 10090
344 4YHY 1 C, L Fab Light Chain 9606
345 5LQB 3 L anti-hIL2 FAB fragment light chain 10090
346 1YEC 1 L IGG2A FAB FRAGMENT (D2.3) CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 10090
347 5I1L 1 A, L FAB LIGHT CHAIN 9606
348 5GGV 1 L light chain 9606
349 6FAB 1 L IGG1-KAPPA 36-71 FAB (LIGHT CHAIN) 10090
350 3L5X 1 L H2L6 LIGHT CHAIN 9606
351 2YMX 2 L FAB ANTIBODY LIGHT CHAIN VARIABLE DOMAIN 10090
352 2NXY 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
353 2R8S 2 L Fab light chain 10090
354 5U3N 2 L DH511.12P Fab Light Chain Fragment of antigen binding 9606
355 4HKZ 1 A Trastuzumab light chain 9606
356 1R3J 1 A Antibody Fab fragment light chain 10090
357 1RIU 1 L Fab M82G2, Light Chain 10090
358 3OKK 1 A S25-39 Fab (IgG1k) light chain 10090
359 3BPC 1 A Fab, antibody fragment (IgG1k), light chain 10090
360 5CHN 2 B, L Antibody 5M16 Fab Light Chain 9606
361 3SO3 2 B A11 FAB light chain 9606
362 5BVJ 1 A, C, E, G canakinumab Fab light-chain 9606
363 4ODT 2 L S1-15 Fab (IgG2b kappa) light chain 10090
364 3IDG 1 A 2F5 Fab light chain 9606
365 2AJX 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
366 5EOQ 2 L Anti vaccinia virus A27 antibody Fab 1G6 light chain 10090
367 3RU8 3 L Antibody b12, Light Chain 9606
368 1KN2 1 L IG ANTIBODY D2.3 (LIGHT CHAIN) 10090
369 1KN4 1 L IG ANTIBODY D2.3 (LIGHT CHAIN) 10090
370 3OAU 2 L Fab 2G12, light chain 9606
371 2BRR 2 L, X MN20B9.34 ANTI-P1.4 ANTIBODY, FAB LIGHT CHAIN 10090
372 3HZV 1 A S73-2 Fab (IgG1k) light chain 10090
373 4WY7 2 L Fab 4E10Light chain 9606
374 5EZJ 2 B Fab c12 Light chain 9606
375 4ZYK 2 B, L AM14 light chain 9606
376 4UIK 2 L FAB 314.1 FAB, LIGHT CHAIN, RESIDUES 1 215 10090
377 1NBZ 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
378 3LS5 1 L Light chain of antibody Fab fragment 10090
379 3FO9 1 A, L Immunoglobulin IGG2A - light chain light chain of 33F12 Fab' fragment 10090
380 5E94 1 A, C Antibody Fab fragment light chain 10090
381 5FB8 1 A Anti-IL-16 antibody 14.1 Fab domain Kappa Chain 10090
382 1E4W 2 L TAB2 MURINE FAB-FRAGMENT IG KAPPA LIGHT CHAIN 10090
383 3U0W 2 L Fab Light Chain, Ig kappa chain C region chimera of Fab Light Chain from mouse, Ig kappa chain C region from human 10090
384 2O5X 1 L chimeric antibody Fab 1E9-DB3 light chain 10090
385 4HIE 1 A Fab 023.102 9606
386 1FL3 2 B, L BLUE FLUORESCENT ANTIBODY (19G2)-LIGHT CHAIN FAB FRAGMENT 10090
387 4LEX 1 L FAB HEAVY CHAIN 10090
388 3QEG 2 L Fab fragment of human anti-HIV antibody N12-i2, light chain Fab light chain 9606
389 3SE9 3 L Light chain of antibody VRC-PG04 antibody light chain 9606
390 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606
391 3EYS 1 L If kappa light chain 10090
392 3WE6 2 B mAb Fab L fragment 10090
393 12E8 1 L, M IGG1-KAPPA 2E8 FAB (LIGHT CHAIN) FAB FRAGMENT 10090
394 5ITB 2 L anti-RSV F Fab 14N4 Light chain 9606
395 1A3R 1 L IGG2A 8F5 FAB (LIGHT CHAIN) FAB FRAGMENT (PAPAIN DIGESTION) 10090
396 3ZL4 2 L A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN 9606
397 1HIL 1 A, C IGG2A-KAPPA 17/9 FAB (LIGHT CHAIN) 10090
398 2NY2 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
399 1F58 1 L PROTEIN (IGG1 ANTIBODY 58.2 (LIGHT CHAIN)) 10090
400 1QKZ 3 L ANTIBODY FAB 10090
401 2G60 1 L anti-FLAG M2 Fab light chain 10090
402 4ODS 2 L S55-3 Fab (IgG2b) heavy chain 10090
403 4KMT 1 L light chain O12/KAPPA Fab 9606
404 2FR4 2 A, L antibody light chain FAB antigen-binding fragment 10090
405 3NZH 1 L 5F6 LIGHT CHAIN 10090
406 1RHH 1 A, C Fab X5, light chain 9606
407 2Q76 1 A, C Fab F10.6.6 fragment Light Chain domain VL and CL 10090
408 1TJG 1 L FAB 2F5 Light Chain 9606
409 1YEF 1 L IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090
410 1YEG 1 L IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090
411 3IFO 2 B, L 10D5 FAB antibody light chain 10090
412 4JPI 2 B, L Putative VRC01 germline Fab light chain 9606
413 4M7J 2 L S25-26 Fab (Igg1k) light chain 10090
414 4XTR 3 D, F Antibody Light chain 32630
415 1UYW 2 L, N FAB ANTIBODY LIGHT CHAIN 10090
416 2XQY 3 K, L A13-D6.3 MONOCLONAL ANTIBODY LIGHT CHAIN OF FAB FRAGMENT 10090
417 3O6K 1 L 11H6H1 Fab' light chain 10090
418 3C5S 1 A, C Fab F22-4 light chain 10090
419 5DQ9 2 B, D, L MAb 44B1 light chain 10090
420 1RZ7 1 L Fab 48d light chain 9606
421 1RZG 2 B, D Fab 412d heavy chain 9606
422 1GPO 1 L, M ANTIBODY M41 FAB FRAGMENT 10090
423 2HVK 2 B Antibody Fab light chain 10090
424 5EA0 2 L Light chain of antibody 7968 Fab fragment 9606
425 1MJJ 1 A, L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
426 5TZU 1 L Light Chain of Fab B6H12.2 9606
427 3PGF 3 L SAB Light Chain 9606
428 5AUM 2 B, L Light chain of Fab fragment 10114
429 1IQD 1 A HUMAN MONOCLONAL BO2C11 FAB LIGHT CHAIN 9606
430 1P2C 1 A, D light chain anti-lysozyme antibody F10.6.6 10090
431 2NY4 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
432 4NJ9 1 L 8B10 light chain 10090
433 1ORS 1 A 33H1 Fab light chain 10090
434 1MLB 1 A IGG1-KAPPA D44.1 FAB (LIGHT CHAIN) 10090
435 4YHL 2 L aDabi-Fab2b light chain 9606
436 2ZKH 1 L Monoclonal TN1 FAB light chain 9606
437 3OJD 1 A Fab V2D2 Light chain 10090
438 2NY3 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
439 3ZKN 3 D, L FAB LIGHT CHAIN 10090
440 1LO0 1 L, X If kappa light chain Fab fragment 10090
441 35C8 1 L IGG 5C8 FAB 10090
442 1MIE 1 L IMMUNOGLOBULIN MS5-393 Fab fragment, LIGHT CHAIN 10090
443 4DVB 2 B, L Fab fragment of pro-uPA antibody mAb-112 10090
444 5I1A 1 A, L CNTO388 LIGHT CHAIN 9606
445 1RFD 1 L Fab M82G2, Light Chain 10090
446 2QQN 3 L Antibody light chain 9606
447 3RVT 1 C Fab fragment of 4C1 antibody - light chain 10090
448 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
449 2NY1 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
450 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606
451 4YHM 2 L aDabi-Fab2b light chain 9606
452 3EOT 2 L FAB FRAGMENT, LIGHT CHAIN 10090
453 4MA7 3 L POM1 light chain Fab 10090
454 1LO2 1 L, X If kappa light chain Fab fragment 10090
455 1UZ6 1 E, L, M, V IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
456 2D03 1 L anti-glycophorin A type N immunoglobulin light chain 10090
457 3UJT 2 L, M Ab-52 light chain Fab fragment 10090
458 5ADP 2 L FAB A.17 LIGHT CHAIN 9606
459 3O6L 1 L 11H6H1 Fab' light chain 10090
460 3E8U 2 L Fab 106.3 light chain 10090
461 1C5B 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
462 3X3F 2 L Light chain of KMTR2 9606
463 4JZN 2 B, D, P Anti-HCV E2 Fab HC84-1 light chain 9606
464 2CMR 3 L D5 9606
465 3GNM 1 L JAA-F11 Fab Antibody Fragment, Light Chain 10090
466 2FD6 2 L L chain of Fab of ATN-615 anti-uPAR antibody 10090
467 4S2S 2 B, L RoAb13 Fab Light chain 10090
468 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606
469 1TET 1 L IGG1 TE33 FAB (LIGHT CHAIN) 10090
470 4BZ2 3 L FAB 2D73 LIGHT CHAIN 10090
471 5CZX 3 D, L 20358 Fab light chain 9606
472 2AEP 3 L FAB light chain 10090
473 4MSW 2 B ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090
474 5CP3 1 A Light Chain of Antigen-Binding Fragment of Monoclonal Antibody of 4C7 10090
475 5H2B 2 B G196 antibody Light chain 10090
476 3GRW 2 L Fab light chain 9606
477 5T6P 1 A, C Fab fragment AR20.5 - Light Chain antibody Fab fragment 10090
478 5IKC 1 A, L MAb 6H10 light chain 10090
479 3LS4 1 L Light chain of antibody Fab fragment 10090
480 1D5I 1 L CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (LIGHT CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. chimeric fab fragment (UNP Q7TS98 reisues 23-129, P01834 residues 1-104) 10090
481 1OSP 1 L FAB 184.1 10090
482 5I1D 1 A, L FAB LIGHT CHAIN 9606
483 1F8T 1 L ANTIBODY FAB FRAGMENT (LIGHT CHAIN) 10090
484 4LSP 3 L LIGHT CHAIN OF ANTIBODY VRC-CH31 9606
485 2R2H 1 A Fab, antibody fragment (IgG1k), light chain 10090
486 1DQJ 1 A ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
487 1RIV 1 L Fab M82G2, Light Chain 10090
488 3QCU 2 L, M LT3015 antibody Fab fragment, light chain 9606
489 1Q9K 1 A S25-2 Fab (IgG1k) light chain Light Chain kappa 10090
490 4OTX 1 L, M N203 light chain Fab 10090
491 1K4C 2 B antibody Fab fragment light chain 10090
492 2NXZ 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
493 1E4X 3 L, M TAB2 MURINE FAB-FRAGMENT IG KAPPA LIGHT CHAIN 10090
494 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606
495 3CLF 1 L Fab light chain 10090
496 5DRX 2 B, L CLL240 BCR light chain 9606
497 4HIX 2 L Humanized 3D6 Fab light chain 10090
498 5B6F 1 A, C, E, G anti-leukotriene C4 monoclonal antibody immunoglobulin kappa light chain 10090
499 4LKC 1 A Fab fragment of PCSK9 antibody 9606
500 1MHH 1 A, C Fab, light chain 10090
501 4GW5 1 A, C Fab Light Chain 10090
502 5X2M 4 K, L Fab16A Light chain 10090
503 4OM1 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
504 5D93 3 B, E Light Chain of Fab Fragment from a Mouse QSOX1-Specific Antibody 10090
505 4KZD 2 L BL3-6 Fab antibody, light chain 10090
506 4HCR 2 L, N PF-547659 light chain 9606
507 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606
508 1C1E 1 L CATALYTIC ANTIBODY 1E9 (LIGHT CHAIN) FAB FRAGMENT 10090
509 1TJH 1 L anti-HIV-1 antibody 2F5 Light Chain 9606
510 1YEK 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090
511 4HIH 1 A, C Fab 023.102 9606
512 1D6V 1 L CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (LIGHT CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. chimeric fab fragment (UNP Q7TS98 reisues 23-129, P01834 residues 1-104) 10090
513 1YY8 1 A, C Cetuximab Fab Light chain 10090
514 4YHK 2 L aDabi-Fab2a light chain 9606
515 4ONG 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
516 4XH2 2 B, D, F, I, K, L Fab Light Chain 9606
517 5TE7 2 L Light chain of N6 9606
518 4ETQ 2 B, L anti-vaccinia D8L antigen murine monoclonal IgG2a antibody LA5, light chain Fab 10090
519 3QPX 1 L Fab C2507 light chain 10116
520 2R0Z 1 L IgG2a Fab fragment light chain light chain 10090
521 3DRQ 1 A 2F5 Fab' light chain 9606
522 3NIG 4 F, L Monoclonal antibody 10E5 light chain 10090
523 5IES 2 L VRC01cHuGL2 Fab light chain 9606
524 4UV7 3 L GC1118A 9606
525 1TJI 1 L anti-HIV-1 antibody 2F5 Light Chain 9606
526 1KEM 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090
527 25C8 1 L IGG 5C8 FAB 10090
528 3QNX 1 A Fab fragment of IMMUNOGLOBULIN A1 LIGHT CHAIN 9606
529 3PHQ 1 A S64-4 Fab (IgG1) light chain 10090
530 5EOC 2 L, M Fab fragment (Light chain) 10090
531 3G5V 1 A 806 light chain 10090
532 4OLZ 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
533 3D0V 1 A 2F5 Fab heavy chain 9606
534 2C1P 1 A, L IGK-C PROTEIN 10090
535 4O51 1 A, C, E, L QAA-2095-2 light chain 9986
536 3S34 1 L 1121B Fab light chain 10090
537 1GAF 1 L CHIMERIC 48G7 FAB BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY CHAIN CONSISTS OF THE VDJ VARIABLE DOMAIN FROM MOUSE AND THE C(H1) CONSTANT REGION FROM HUMAN VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606
538 2P7T 2 B FAB-B 10090
539 3MOD 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606
540 4HXA 1 L 13D9 FAB LIGHT CHAIN 10090
541 5E2T 1 L AT8 LIGHT CHAIN 10090
542 1NDM 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-26 light chain 10090
543 2IQA 1 A, L IgG2a Fab fragment PFA2 Kappa light chain 10090
544 1H0D 1 A ANTIBODY FAB FRAGMENT, LIGHT CHAIN HINGE REGION OBSERVED IN THE FAB FRAGMENT 9606
545 2F5B 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606
546 3MNW 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
547 1IL1 2 B monoclonal antibody G3-519 (light chain) FAB FRAGMENT 10090
548 1U8I 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
549 2VDR 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090
550 2RCS 1 L IMMUNOGLOBULIN 48G7 GERMLINE FAB VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 10090
551 1JGL 1 L Ig kappa-chain 10090
552 4G6J 3 L light chain of antibody binding fragment of canakinumab light chain of antibody binding fragment of canakinumab 9606
553 2AJ3 1 A, C, E Fab m18, Light Chain 9606
554 5DLM 2 L, M Light chain of monoclonal antibody 10090
555 1SY6 1 L OKT3 Fab light chain fab fragment light chain 10090
556 3T3P 4 F, L Monoclonal antibody 10E5 light chain 10090
557 5BVP 3 L Canakinumab Fab light-chain 9606
558 1EMT 1 L IGG ANTIBODY (LIGHT CHAIN) FAB FRAGMENT 10090
559 5D96 2 B, I Light chain of Fab fragment from an antibody targeting mouse and human QSOX1 10090
560 3IDI 1 A 2F5 Fab light chain 9606
561 1CLO 1 L A5B7 MONOCLONAL ANTIBODY ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7 ANTIGEN BINDING FRAGMENT, FAB 10090
562 3PNW 1 A, D, G, J, M, P, S, V FAB light chain 32630
563 1FE8 3 L, M, N IMMUNOGLOBULIN IGG RU5 FAB FRAGMENT LIGHT CHAIN 10090
564 3QO0 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606
565 4NRX 3 B, E, L m66 Light Chain 9606
566 2Y5T 2 B CIIC1 FAB FRAGMENT LIGHT CHAIN DISULFIDE BRIDGE BETWEEN B23 AND B92, B138 AND B198 10090
567 1L7T 1 L anti-testosterone (light chain) fab77 fragment 10090
568 3O2D 1 L ibalizumab light chain 10090
569 4GW1 1 A, C Fab light chain 10090
570 3HI6 3 L, Y light chain of Fab fragment of AL-57 against alpha L I domain 9606
571 3IJH 1 A, C Immunoglobulin light chain (IGG3) 10090
572 1XGP 1 A antibody kappa light chain 10090
573 4ZFG 3 L Fragment antigen binding 5A12 light chain 9606
574 5V7R 1 L CBTAU-7.1 Fab light chain 9606
575 2VL5 2 B, D CIIC1 ANTICOLLAGEN FAB 10090
576 1YNK 1 L immunoglobulin kappa light chain 10090
577 5T78 1 A, C Fab fragment AR20.5 - Light Chain antibody Fab fragment 10090
578 1DQD 1 L FAB HGR-2 F6 LIGHT CHAIN 10090
579 1AJ7 1 L IMMUNOGLOBULIN 48G7 FAB (LIGHT CHAIN) VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 10090
580 2R0L 1 L antibody light chain 32630
581 4M93 1 C, L S25-26 Fab (IgG1k) light chain 10090
582 1DN0 1 A, C IGM-KAPPA COLD AGGLUTININ (LIGHT CHAIN) FAB FRAGMENT 9606
583 2PCP 1 A, C IMMUNOGLOBULIN COMPLEXED WITH 1-(1-PHENYLCYCLOHEXYL) PIPERIDINE (PCP, OR PHENCYCLIDINE) FAB 10090
584 1AY1 1 L TP7 FAB FAB 10090
585 4ODV 1 L A6 Fab (IgG2b kappa) light chain 10090
586 1MH5 1 A, L IMMUNOGLOBULIN MS6-164 Fab fragment, LIGHT CHAIN 10090
587 4MA8 3 L POM1 light chain Fab 10090
588 4P9M 1 L 8ANC195 light chain 8ANC195 LIGHT CHAIN 9606
589 5X2N 4 K, L Fab16A Light chain 10090
590 3SGD 1 I, L Light Chain 10090
591 3HZY 1 A S73-2 Fab (IgG1k) light chain 10090
592 3GIZ 1 L Fab fragment of anti-CD20 antibody Ofatumumab, light chain 9606
593 2HRP 1 L, M MONOCLONAL ANTIBODY F11.2.32 FAB FRAGMENT 10090
594 3QNZ 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606
595 1I8M 3 A, L ANTIBODY LIGHT CHAIN FAB 10090
596 5U3L 2 B, L DH511.2 Fab Light Chain 9606
597 3NID 4 F, L Monoclonal antibody 10E5 light chain 10090
598 3Q1S 1 L Z13e1 Fab light chain 9606
599 1U8H 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
600 3FO2 1 A, L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090
601 1KCU 1 L PC287 IMMUNOGLOBULIN light chain 10090
602 2CK0 1 L PROTEIN (IMMUNOGLOBULIN; LIGHT CHAIN) IGG1, KAPPA FAB FRAGMENT 10090
603 1AXT 1 L IMMUNOGLOBULIN IGG2A FAB' FRAGMENT 33F12 10090
604 1VPO 1 L anti-testosterone (light chain) fab77 fragment 10090
605 5F96 3 L LIGHT CHAIN OF ANTIBODY CH235.12 9606
606 1NBV 1 L IGG2B-KAPPA BV04-01 FAB (LIGHT CHAIN) 10090
607 4IMK 2 C, D Light Chain 9606
608 1OAK 1 L NMC-4 IGG1 THE ANTIBODY HEAVY CHAIN CONSISTS OF TWO SEGMENTS, H1 AND H2, BOTH LABELED CHAIN H IN THIS ENTRY FAB FRAGMENT, AN ANTI VON WILLEBRAND FACTOR (VWF) A1 DOMAIN 10090
609 1XGU 1 A antibody kappa light chain 10090
610 4JZO 2 B, E, F, H Anti-HCV E2 Fab HC84-27 light chain 9606
611 2F5A 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606
612 4OLU 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
613 3KR3 3 L antibody-Fab (light chain) 9606
614 5DK3 1 A, F Light Chain 9606
615 2HKH 1 L Immunoglobulin Light chain Fab fragment 10090
616 1UB5 2 B, L antibody 19G2, beta chain 10090
617 4KVC 2 L Ig kappa chain V-V region MOPC 21, Anti-colorectal carcinoma light chain 10090
618 4R97 1 B platelet factor 4 antibody KKO light chain 10090
619 4OLX 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
620 2AJY 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
621 1DQM 1 L ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
622 4YUE 2 L S4B6 Fab light chain 10090
623 4XNY 3 L LIGHT CHAIN OF ANTIBODY VRC08C 9606
624 1YEE 1 L IGG2A FAB FRAGMENT (D2.5) TRANSITION STATE ANALOGUE 10090
625 1QBL 1 L FABE8A IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
626 2NY0 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
627 4LSQ 3 L LIGHT CHAIN OF ANTIBODY VRC-CH31 WITH N70D MUTATION 9606
628 3ZE2 4 F, L 10E5 FAB LIGHT CHAIN 10090
629 4YHZ 2 L Fab Light Chain 9606
630 4RWY 3 L Antibody 8ANC131 Light chain 9606
631 4LVO 2 B NIMP.M7 Fab light chain 10090
632 4YHN 2 B, L aDabi-Fab3 light chain 9606
633 5GGU 2 B, L light chain 9606
634 3MOA 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606
635 2VDO 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090
636 3S35 2 L 6.64 Fab light chain 10090
637 3HZK 1 A S73-2 Fab (IgG1k) light chain 10090
638 3QO1 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606
639 3OKN 1 A S25-39 Fab (IgG1k) light chain 10090
640 2PR4 1 L nmAb 2F5 Fab' Heavy Chain 9606
641 4D9Q 2 D, L Anti-Factor D, light chain 9606
642 1A4J 1 A, L IMMUNOGLOBULIN, DIELS ALDER CATALYTIC ANTIBODY (LIGHT CHAIN) FAB 10090
643 5KW9 3 L IgA Light chain 9606
644 3QNY 1 A, C FAB FRAGMENT OF IMMUNOGLOBULIN A1 LIGHT CHAIN 9606
645 4LVN 2 B NIMP.M7 Fab light chain 10090
646 5MI0 3 C MONOCLONAL ANTIBODY 9AD4 10090
647 3VG0 1 L Monoclonal antibody 9F8 Fab fragment L chain 10090
648 4ODU 1 B, L S1-15 Fab (IgG2b kappa) light chain 10090
649 5JOR 2 A, C, E, L Fab 14.22 light chain 10090
650 4PLJ 2 C, L 8G12 light chain 10090
651 1BGX 2 L TP7 MAB FAB 10090
652 1YYM 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606
653 3ZDX 4 F, L 10E5 FAB, LIGHT CHAIN 10090
654 3DGG 1 A, C FabOX108 Light Chain Fragment 9606
655 1MJ7 1 L IMMUNOGLOBULIN MS5-393 Fab fragment, LIGHT CHAIN 10090
656 2Z4Q 1 A anti egfr antibody fab, light chain 10090
657 1CT8 1 A, C 7C8 FAB FRAGMENT; SHORT CHAIN 10090
658 5DRW 2 B CLL183 BCR antibody light chain 9606
659 5T1L 1 A, C CETUXIMAB FAB LIGHT CHAIN 10090
660 1FL5 1 A, L ANTIBODY GERMLINE PRECURSOR TO ANTIBODY 28B4 LIGHT CHAIN (CHAINS L AND A) 10090
661 2VDQ 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090
662 2O5Z 1 L chimeric antibody Fab 1E9-DB3 light chain 10090
663 4OM0 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
664 1MRE 1 L IGG2B-KAPPA JEL103 FAB (LIGHT CHAIN) 10090
665 5MVZ 2 B, L Fab 4AB007 L-chain 9606
666 5FF6 1 A, C Cetuximab Fab light chain 10090
667 3AAZ 2 B, L Humanized recombinant Fab fragment of a murine; antibody 9606
668 4QXG 2 L Fab, light chain, IgG1 Fab, light chain 9606
669 3WFD 1 L antibody fab fragment light chain 10090
670 1XGQ 1 A antibody kappa light chain 10090
671 3O2V 1 L Chimeric antibody Fab 1E9, light chain 10090
672 3NIF 4 F, L Monoclonal antibody 10E5 light chain 10090
673 4LSR 3 L LIGHT CHAIN OF ANTIBODY VRC-CH31 (N70D MUTATION) 9606
674 2I5Y 2 L, Q Antibody 17B Light chain ANTIGEN-BINDING FRAGMENT, FAB 9606
675 2CGR 1 L IGG2B-KAPPA NC6.8 FAB (LIGHT CHAIN) 10090
676 5T1K 1 A, C CETUXIMAB FAB LIGHT CHAIN 10090
677 5ID0 1 A, C Cetuximab Fab light chain 10090
678 2FX9 1 L, M Fab 4E10 Light Chain 9606
679 4BZ1 3 L FAB 3E31 LIGHT CHAIN 10090
680 1MRD 1 L IGG2B-KAPPA JEL103 FAB (LIGHT CHAIN) 10090
681 4WHT 2 B, D, F, H, J, L, N, P, R, T, V, Y Light chain of the Fab fragment derived from neutralizing antibody 3/11 10116
682 5T1M 1 A, C CETUXIMAB FAB LIGHT CHAIN 10090
683 3C08 1 L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
684 2NY7 3 L ANTIBODY b12, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
685 3U1S 1 L Fab PGT145 Light chain fragment antigen binding 9606
686 5ICY 1 A, C Cetuximab Fab light chain 10090
687 1BZ7 1 A PROTEIN (ANTIBODY R24 (LIGHT CHAIN)) FAB 10090
688 5F88 1 A, C Cetuximab Fab light chain 10090
689 1TZG 1 L, M Fab 4E10 light chain 9606
690 4YX2 3 L POM1 FAB LIGHT CHAIN 10090
691 5IR1 1 A, C Cetuximab Fab light chain 10090
692 3W9D 2 B, D Antibody Fab light chain 9606
693 2VXU 2 L, M MURINE IGG 125-2H 10090
694 1U95 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
695 5IV2 1 A, C Cetuximab Fab, light chain 10090
696 1IKF 1 L IGG1-KAPPA R45-45-11 FAB (LIGHT CHAIN) 9606
697 5HYQ 1 A, C Cetuximab light chain 10090
698 4LQF 3 L Murine IgG2b A2C7 Light chain Fab domain 10090
699 4NRZ 2 B, L M66.6 LIGHT CHAIN Fab Light Chain 9606
700 4NJA 1 L 6C8 light chain 10090
701 1NCB 2 L IGG2A-KAPPA NC41 FAB (LIGHT CHAIN) 10090
702 3BN9 2 C, E E2 Fab Light Chain 9606
703 3MNV 1 A, C ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
704 3GK8 1 L Fab 14 Light Chain 10090
705 4HWE 2 L Fab light chain light chain 9606
706 4AEI 3 L, M, N FAB ANTIBODY LIGHT CHAIN VARIABLE DOMAIN 10090
707 1MRF 1 L IGG2B-KAPPA JEL103 FAB (LIGHT CHAIN) 10090
708 2AI0 1 L, M, N, O Immunoglobulin Light Chain kappa 10090
709 1S5H 1 A ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090
710 1IQW 1 L ANTIBODY M-HFE7A, LIGHT CHAIN FAB FRAGMENT 10090
711 1A0Q 1 L 29G11 FAB (LIGHT CHAIN) PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL]PHOSPHONATE HAPTEN FAB 10090
712 1U8K 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
713 1XF2 2 A, L antibody light chain Fab 10090
714 3MCK 1 A, L C705 MONOCLONAL LIGHT CHAIN 10090
715 1T66 1 C, L immunoglobulin light chain FAB 10090
716 5TZ2 2 L C47B222 Fab Light Chain 9606
717 2H1P 1 L 2H1 FAB 10090
718 1EAP 1 A IGG2B-KAPPA 17E8 FAB (LIGHT CHAIN) 10090
719 5I2I 1 A, C Cetuximab Fab light chain 10090
720 4OCX 2 L Fab ADD056 Light Chain 10090
721 4QTH 2 B, L anti-uPAR antibody, light chain 10090
722 1UWX 3 K, L ANTIBODY RESIDUES 3-214 (FAB FRAGMENT, LIGHT CHAIN) 10090
723 3L95 1 A, L anti-NRR1 fab fragment light chain 9606
724 3V0V 1 B, L WN1 222-5 Fab (IgG2a) light chain 10090
725 4OGX 3 L DX-2930 LIGHT CHAIN 9606
726 3W9E 3 B Antibody Fab light chain 9606
727 5TFS 2 L 02-K Fab Light chain 9606
728 5DYO 2 B, L Fab 43.1 Light Chain 10090
729 3UTZ 1 A, D, E Metalloproteinase, light chain 10090
730 5E2U 1 L AT8 LIGHT CHAIN 10090
731 1QBM 1 L E8B ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB FRAGMENT 10090
732 1OM3 1 L, M FAB 2G12, light chain light chain 9606
733 4KZE 2 L BL3-6 Fab antibody, light chain 10090
734 3WKM 3 L, M MOUSE IGG1-KAPPA FAB (LIGHT CHAIN) 10090
735 5WT9 2 L Light Chain of Nivolumab 9606
736 5X2Q 4 K, L Fab16A Light chain 10090
737 4HIJ 1 A, C Fab 023.102 light chain 9606
738 1LO3 1 L, X If kappa light chain Fab fragment 10090
739 3FO1 1 A, L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090
740 4XVU 3 D, F, J, L Antibody light chain 32630
741 5ID1 1 A, C Cetuximab Fab light chain 10090
742 5X2P 4 K, L Fab16A Light chain 10090
743 5EBL 2 B Antibody Fab Fragment Light Chain 10090
744 1XGR 1 A antibody kappa light chain 10090
745 5B71 1 A, C SKY59 Fab light chain 9606
746 3ZDY 4 F, L 10E5 FAB LIGHT CHAIN 10090
747 1MRC 1 L IGG2B-KAPPA JEL103 FAB (LIGHT CHAIN) 10090
748 5EUK 1 A, C Cetuximab Fab light chain 10090
749 3IET 1 A, C Immunoglobulin light chain (IgG2a) 10090
750 1XF3 1 A, L Fab Light chain 10090
751 2BMK 1 A, L FAB FRAGMENT OF CATALYTIC ANTIBODY 15A9, LIGHT CHAIN 10090
752 3QCT 2 L LT3015 antibody Fab fragment, light chain 9606
753 3EYF 1 A, C 8f9 Fab 9606
754 3NAB 1 L Fab15 Mut6 light chain 9606
755 3IDN 1 A 2F5 Fab light chain 9606
756 5IVZ 1 A, C Cetuximab Fab, light chain 10090
757 1XGT 1 A antibody kappa light chain 10090
758 1IGJ 1 A, C IGG2A-KAPPA 26-10 FAB (LIGHT CHAIN) 10090
759 2Q8B 2 L 1F9 light chain 10090
760 5I1C 1 L FAB LIGHT CHAIN 9606
761 1RZ8 1 A, C Fab 17b light chain 9606
762 4WV1 3 A, D Fab light chain 9606
763 1Q9L 2 A, C S25-2 Fab (IgG1k) light chain Fab Light chain kappa 10090
764 5EII 2 B, L Fab Light Chain 9606
765 4UUJ 2 B ANTIBODY FAB FRAGMENT HEAVY CHAIN 10090
766 5KNA 2 L IgG4 Light Chain 9606
767 5EZL 2 B, L Fab c12 10090
768 4OLY 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
769 4FNL 2 L, M Antibody C05, Light Chain 9606
770 4UB0 2 L IgG1, light chain 9606
771 2DTM 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
772 1U92 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
773 4KAQ 1 L Rituximab light chain 10090
774 1CIC 1 A PROTEIN (IG HEAVY CHAIN V REGIONS) FAB IMMUNOGLOBULIN FRAGMENT 10090
775 1CIC 3 C PROTEIN (IG HEAVY CHAIN V REGIONS) FAB IMMUNOGLOBULIN FRAGMENT 10090
776 1FVD 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
777 1C5D 1 A, L MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR FAB FRAGMENT, HEAVY CHAIN 10116
778 1BJ1 1 J, L FAB FRAGMENT HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 10090
779 5IOP 1 A, C Cetuximab Fab, light chain 10090
780 1U91 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
781 5TIH 3 L CyRPA antibody Fab Light Chain 10090
782 5I1H 1 L FAB LIGHT CHAIN 9606
783 5VPH 2 C FAB 4C1 - LIGHT CHAIN 10090
784 2IQ9 1 L IgG2a Fab fragment PFA2 Kappa light chain 10090
785 1F90 1 L FAB FRAGMENT OF MONOCLONAL ANTIBODY 10090
786 3RVX 2 C 4C1 - light chain 10090
787 2FX8 1 L, M, N, O Fab 4E10 Light Chain 9606
788 1NGY 1 A Mature Metal Chelatase Catalytic Antibody, Light chain Fab fragment 10090
789 4G6A 3 D, L AP33 Light chain antibody Fab 9606
790 1M7D 1 A light chain of the monoclonal antibody Fab SYA/J6 10090
791 5I1J 1 L FAB LIGHT CHAIN 9606
792 3IDX 3 L Fab b13 light chain 9606
793 1U8Q 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
794 5ICZ 1 A, C Cetuximab Fab light chain 10090
795 5CIP 2 B, L FAB 4E10 LIGHT CHAIN 9606
796 1EHL 2 L ANTI-(6-4) PHOTOPRODUCT ANTIBODY 64M-2 FAB (LIGHT CHAIN) 10090
797 2VDL 4 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090
798 3IDJ 1 A 2F5 Fab light chain 9606
799 3IDM 1 A 2F5 Fab light chain 9606
800 1U8J 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
801 1ZLV 1 K, L FAB 2G12, light chain FAB, Light Chain 9606
802 5IF0 2 B, L VRC01c-HuGL2 Fab light chain 9606
803 4K94 1 L Fab19 heavy chain 9606
804 1K4D 2 B antibody Fab fragment light chain 10090
805 1IGC 1 L IGG1-KAPPA MOPC21 FAB (LIGHT CHAIN) 10090
806 1ZLS 1 L FAB 2G12, light chain FAB, Light Chain 9606
807 4L5F 3 L Light chain of E106 antibody (kappa) VL anD CL domains 10090
808 1RIH 1 L light chain of antibody 14F7 Fab 10090
809 1MLC 1 A, C IGG1-KAPPA D44.1 FAB (LIGHT CHAIN) 10090
810 1FDL 1 L IGG1-KAPPA D1.3 FAB (LIGHT CHAIN) 10090
811 3V6F 2 B, D, F, L Fab e6 Light Chain 10090
812 5K9Q 4 I, K, L, T, V, Y 16.a.26 Light chain 9606
813 2W65 2 B, D ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
814 1I7Z 1 A, C CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION THE CHIMERA CONSISTS OF RESIDUES 1-108 OF MOUSE PORTION AND 109-214 OF HUMAN PORTION OF IG KAPPA CHAIN. 10090
815 4KI5 2 D MURINE MONOCLONAL 3E6 FAB LIGHT CHAIN 10090
816 4KI5 4 F MURINE MONOCLONAL G99 FAB LIGHT CHAIN 10090
817 3D0L 1 A 2F5 heavy chain 9606
818 5KMV 2 I, L IgG4 light chain 9606
819 4JPK 2 L Putative VRC01 germline precursor Fab light chain 9606
820 3QG6 1 A, L AP4-24H11 Light Chain 10090
821 2B2X 3 L, M Antibody AQC2 Fab AQC2 Fab Light Chain 10090
822 1XF4 1 A, L Fab light chain 10090
823 5XAJ 2 B, L FabHM14c10 light chain 12637
824 4ZD3 2 L 679-14-14E06 Fab fragment light chain 9606
825 5VEB 2 B, L anti-CDH6 Fab light chain 9606
826 5ITF 1 A, C Cetuximab Fab, light chain 10090
827 4WEB 3 L Mouse Fab Light Chain 10090
828 2W0F 2 B ANTIBODY FAB FRAGMENT HEAVY CHAIN 10090
829 2HFE 2 B FAB Light Chain 10090
830 4HT1 3 L chimeric antibody Fab 9986
831 2Q8A 2 L 1F9 light chain 10090
832 5ETU 1 A, C Cetuximab Fab light chain 10090
833 4U0R 3 C Monoclonal antibody 9AD4 light chain 10090
834 2JK5 2 B ANTIBODY FAB FRAGMENT HEAVY CHAIN 10090
835 2H8P 2 B FAB light chain 10090
836 1YEH 1 L FAB FRAGMENT IG GAMMA-2A CHAIN C REGION (D2.3) 10090
837 3WFE 1 L antibody fab fragment light chain 10090
838 3FCT 1 A, C PROTEIN (METAL CHELATASE CATALYTIC ANTIBODY) CHIMERIC FAB FRAGMENT FAB FRAGMENT 9606
839 3X3G 2 L Light chain of KMTR2 9606
840 2J4W 3 L FAB FRAGMENT OF MONOCLONAL ANTIBODY F8.12.19 MONOCLONAL ANTIBODY ISOTYPE IS IGG1, KAPPA 10090
841 15C8 1 L IGG 5C8 FAB (LIGHT CHAIN) FAB 10090
842 5EBW 2 B Antibody Fab Fragment Light Chain 10090
843 1KEG 2 L Anti-(6-4) photoproduct antibody 64M-2 Fab (light chain) 10090
844 1NCA 2 L IGG2A-KAPPA NC41 FAB (LIGHT CHAIN) 10090
845 5E08 2 L Fab Light Chain 9606
846 2P8L 1 A nmAb 2F5, light chain 9606
847 1CZ8 2 L, X LIGHT CHAIN OF NEUTRALIZING ANTIBODY MUTATED FORM OF A HUMANIZED MURINE ANTIBODY LIGHT CHAIN 10090
848 5IBT 2 L UCA Light Chain 9606
849 1RU9 1 L immunoglobulin igg2a, light chain fab 10090
850 1CK0 1 L PROTEIN (IGG1-KAPPA ANTIBODY 131 (LIGHT CHAIN)) FAB 10090
851 4X8J 1 B, L 12F4 FAB Light chain 10090
852 1UB6 2 B, L antibody 19G2, beta chain 10090
853 4XAK 3 E, L Light chain of neutralizing antibody m336 9606
854 4HXB 1 L 6B9 FAB LIGHT CHAIN 10090
855 3WFC 1 L antibody fab fragment light chain 10090
856 3R06 1 A, C, E, L anti-mouse CD3epsilon antibody 2C11 Fab light chain 10032
857 1WC7 1 A, L FAB FRAGMENT OF CATALYTIC ANTIBODY 15A9, LIGHT CHAIN 10090
858 3G5X 1 A, C 806 light chain 10090
859 2Z92 2 B Anti-ciguatoxin antibody 10C9 Fab light chain 10090
860 4YR6 2 B, E light chain of 5G6 10090
861 5E8D 3 L anti-human epiregulin antibody 9E5 Fab light chain 10090
862 5JQ6 3 L Tefibazumab FAB FRAGMENT LIGHT CHAIN 10090
863 1A4K 1 A, L ANTIBODY FAB FAB 10090
864 5ICX 1 A, C Cetuximab Fab light chain 10090
865 1CF8 1 L PROTEIN (CATALYTIC ANTIBODY 19A4 (LIGHT CHAIN)) FAB, VARIABLE REGION 10090
866 3T3M 4 F, L Monoclonal antibody 10E5 light chain 10090
867 1KC5 1 L PC287 Immunoglobulin light chain 10090
868 4I2X 1 A, C FabOX117 light chain 9606
869 3HR5 1 A, L, P, Q Fab h47H4 light chain 10090
870 4K2U 3 L, M Antibody Light Chain 10090
871 3O6M 1 L 11H6H1 Fab' light chain 10090
872 5EC2 2 B Antibody Fab Fragment Light Chain 10090
873 2I60 2 L, Q ANTIBODY 17B LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
874 1A6T 1 A, C IGG1 FAB1-IA FAB (LIGHT CHAIN) FAB FRAGMENT 10090
875 4NGH 1 L FAB LIGHT CHAIN 9606
876 2G5B 1 A, C, E, G 6A7 Fab Light Chain 10090
877 4EDW 2 L tanezumab Fab light chain 9606
878 2DDQ 2 L R310 antibody light chain 10090
879 4MA1 2 C, F, L S25-26 Fab (IgG1k) light chain 10090
880 1UCB 1 L CHIMERIC HUMAN/MOUSE IGG FAB FRAGMENT BR96 MOUSE VH AND VL DOMAINS, HUMAN CL KAPPA AND CH1 IGG1 DOMAINS 9606
881 5ESQ 1 A, C Cetuximab Fab light chain 10090
882 1FVE 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
883 2NY5 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
884 4NM4 1 L, M Antibody CR8043, Light Chain 9606
885 4LST 3 L LIGHT CHAIN OF ANTIBODY VRC01 9606
886 2VDP 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090
887 4WFE 2 D, F ANTI-TRAAK ANTIBODY 13E9 FAB FRAGMENT LIGHT CHAIN 10090
888 3U7Y 3 L NIH45-46 light chain, Ig kappa chain C region 9606
889 1U8M 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
890 1R3I 1 L Antibody Fab fragment light chain 10090
891 4D9R 2 D, L Fab light chain 9606
892 4F3F 1 A MORAb-009 Fab light chain 10090
893 3U7W 2 L Light chain, Ig kappa chain C region 9606
894 2H9G 1 A, L Fab BdF1, light chain Fab fragment 9606
895 4G7V 2 L fragment antibody light chain 9606
896 2ADG 1 A Q425 Fab Light chain 10090
897 4HDI 1 A, L Kappa light chain variable region, Anti-colorectal carcinoma light chain 10090
898 2AJZ 1 A, L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
899 5ESA 2 B Anti-HCV E2 glycoprotein Fab light chain 9606
900 1I9J 1 L RECOMBINANT MONOCLONAL ANTI-TESTOSTERONE FAB FRAGMENT LIGHT CHAIN 10090
901 5W06 2 L M1587 FAB LIGHT CHAIN 10090
902 4HFW 1 A, L 6-26 Fab Light chain 9606
903 3L7E 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
904 1Y0L 1 A, C, E, L Catalytic Antibody Fab 34E4 Light chain THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE. 10090
905 2XRA 3 L HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN 9606
906 5X2O 4 K, L Fab16A Light chain 10090
907 4LIQ 3 L Fab fragment RG7155 light chain Humanized Version of a monoclonal murine. 10090
908 4S1Q 3 L Fab of VRC01 light chain Fab of VRC01 light chain 9606
909 4KQ4 1 L CNTO7357 light chain Fab (mouse variable domain, human constant domain) 10090
910 3INU 2 L, N KZ52 antibody fragment light chain 9606